We are live on
!
Find out more
FC
Fairpointe Capital Portfolio holdings
AUM
$66.3M
1-Year Est. Return
101.32%
This Fund
S&P 500
This Quarter
Est. Return
+4.4%
1 Year Est. Return
+101.32%
3 Year Est. Return
+48.06%
5 Year Est. Return
+95.29%
10 Year Est. Return
–
AUM
$7.59B
AUM Growth
+$109M
(+1.5%)
Cap. Flow
-$109M
Cap. Flow
% of AUM
-1.44%
Top 10 Holdings %
Top 10 Hldgs %
30.19%
Holding
82
New
3
Increased
37
Reduced
37
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Transocean
RIG
|
+$142M |
| 2 |
Wolfspeed
WOLF
|
+$65.8M |
| 3 |
X
US Steel
X
|
+$55.9M |
| 4 |
Gerdau
GGB
|
+$53.1M |
| 5 |
FMC
FMC
|
+$52M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPLS
Staples Inc
SPLS
|
+$183M |
| 2 |
Factset
FDS
|
+$77.8M |
| 3 |
Edwards Lifesciences
EW
|
+$71.4M |
| 4 |
Alcoa
AA
|
+$36.3M |
| 5 |
HSP
HOSPIRA INC
HSP
|
+$27.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.78% |
| 2 | Industrials | 13.99% |
| 3 | Consumer Discretionary | 11.24% |
| 4 | Materials | 9.6% |
| 5 | Communication Services | 8.43% |
Similar funds
EFM
NI
UL
WSC
AGEC
CIA
FLSMF
OHS
Fairpointe Capital's Q4 2014 Portfolio in Review
As of Q4 2014, Fairpointe Capital held 82 positions worth $7.59B, up 1.5% from $7.48B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Fairpointe Capital's Q4 2014 filing shows 3 new, 37 increased, 37 reduced and 2 closed positions. Its largest new stake was State Street SPDR S&P MIDCAP 400 ETF Trust: 24,910 shares worth $6.58M. The largest sale was Staples Inc, an estimated $183M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 28% a quarter earlier, followed by Industrials and Consumer Discretionary.
- Fairpointe Capital's largest Q4 2014 buy was State Street SPDR S&P MIDCAP 400 ETF Trust: 24,910 shares worth $6.58M.
- Fairpointe Capital added most to Transocean in Q4 2014, an estimated $142M increase.
- Fairpointe Capital's biggest Q4 2014 reduction was Staples Inc, cutting an estimated $183M.
- Fairpointe Capital fully exited Edwards Lifesciences in Q4 2014, selling an estimated $71.4M.
- Fairpointe Capital's ten largest holdings make up 30% of its $7.59B portfolio in Q4 2014.
- Fairpointe Capital opened 3 new positions and closed 2 in Q4 2014.
- Fairpointe Capital's portfolio value rose 1.5% quarter-over-quarter to $7.59B.
Based on Fairpointe Capital's 13F filing for Q4 2014, filed 11 Feb 2015.